E. Joosens

Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma

Bart Neyns, Jan Sadones, E. Joosens et al. · Annals of Oncology · 2009 · 239 citations · Full text

Medicine, Metronomic Therapy, Recurrent High-grade Glioma +8

Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015

C.-H. Köhne, Jacques De Grève, J. T. Hartmann et al. · Annals of Oncology · 2007 · 161 citations

Gastrointestinal Oncology, Medicine, Infusional 5-Fluorouracil/folinic Acid +8

Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study

D. Schrijvers, C. van Herpen, Joseph Kerger et al. · Annals of Oncology · 2004 · 86 citations · Full text

Neck Cancer, Medicine, Unresectable Head +8

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 85 citations · Full text

Advanced Ovarian Cancer, Medicine, Pharmacology +9

A Multicenter Cohort Study of Dose-Dense Temozolomide (21 of 28 Days) for the Treatment of Recurrent Anaplastic Astrocytoma or Oligoastrocytoma

Bart Neyns, C. Chaskis, E. Joosens et al. · Cancer Investigation · 2008 · 39 citations

Cancer Management, Pathology, Surgery +16